Casdin Capital, LLC Relay Therapeutics, Inc. Transaction History
Casdin Capital, LLC
- $713 Million
- Q2 2025
A detailed history of Casdin Capital, LLC transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Casdin Capital, LLC holds 11,398,574 shares of RLAY stock, worth $38.2 Million. This represents 5.53% of its overall portfolio holdings.
Number of Shares
11,398,574
Previous 9,098,574
25.28%
Holding current value
$38.2 Million
Previous $23.8 Million
65.45%
% of portfolio
5.53%
Previous 2.79%
Shares
17 transactions
Others Institutions Holding RLAY
# of Institutions
213Shares Held
172MCall Options Held
0Put Options Held
36.1K-
Sb Investment Advisers (Uk) LTD London, X027.9MShares$93.5 Million0.77% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct13.4MShares$45 Million0.1% of portfolio
-
Commodore Capital LP New York, NY13.4MShares$44.7 Million4.31% of portfolio
-
Black Rock Inc. New York, NY10.5MShares$35.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.38MShares$31.4 Million0.0% of portfolio
About Relay Therapeutics, Inc.
- Ticker RLAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 120,219,000
- Market Cap $403M
- Description
- Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...